1-3 of 3
Nicholas Veomett
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Bi-Specific T Cell Engaging Monoclonal Antibody (mAb) Derived From a TCR-Like Mab Specific For WT1/HLA-A0201 (ESK-BiTE) Shows a Potent Activity Against Human AML and Ph+ ALL In Mouse Models

Dmitry Pankov, MD, Tao Dao, MD, PhD, Yiyang Wang, Andrew Scott, Tatyana Korontsvit, MD, Victoria Zakhaleva, Nicholas Veomett, Michael Curcio, Ekaterina Doubrovina, MD, PhD, Richard J. O'Reilly, MD, Cheng Liu, PhD, David A. Scheinberg, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2521.
https://doi.org/10.1182/blood.V122.21.2521.2521
Published: 2013
Journal Articles

Therapeutic Efficacy and Cure Of Sensitive and T315I Pan-Resistant Human Ph+ Leukemia In Mice Using a TCR-Like Antibody To WT1/HLA-A0201 Alone, Or In Combination With Tyrosine Kinase Inhibitors

Leonid Dubrovsky, MD, Elliott Brea, Dmitry Pankov, MD, Nicholas Veomett, Tao Dao, MD/PhD, Su Yan, PhD, Cheng Liu, PhD, David A. Scheinberg, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 855.
https://doi.org/10.1182/blood.V122.21.855.855
Published: 2013
Journal Articles

Native and Fc Enhanced Therapeutic Human Monoclonal Antibodies Targeting the Intracellular WT1 Oncogene Product in Leukemia.

Nicholas Veomett, Tao Dao, MD, PhD, Dmitry Pankov, MD, Su Yan, PhD, Richard J. O'Reilly, MD, Cheng Liu, PhD, David A. Scheinberg, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 2599.
https://doi.org/10.1182/blood.V120.21.2599.2599
Published: 2012